AbbVie Inc. (ABBV) operating KPIs
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)
Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%
AbbVie viekira (ombitasvir/paritaprevir/ritonavir) [legacy through FY20Q1] — International net revenues ($M) ($M)
Form 10-Q / 10-K Segment & Revenue Disaggregation Note & Form 8-K Key Product Revenues
Latest, Q1 2020
5
Period ended Mar 31, 2020
Change on a year earlier
-80.0%
25 in Q1 2019
History
11 quarters
Since Q3 2017
Sources
6
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Viekira (ombitasvir/paritaprevir/ritonavir) [legacy through FY20Q1] — International net revenues ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q1 2020 | Mar 31, 2020 | 5 | -80.0% | Form 10-Q (filed 2020-05-08) ↗ |
| Q4 2019 | Dec 31, 2019 | 4 | -90.7% | Form 10-K (filed 2020-02-21) ↗ |
| Q3 2019 | Sep 30, 2019 | 3 | -87.0% | Form 10-Q (filed 2019-11-06) ↗ |
| Q2 2019 | Jun 30, 2019 | 4 | -90.2% | Form 10-Q (filed 2019-08-05) ↗ |
| Q1 2019 | Mar 31, 2019 | 25 | -63.2% | Form 10-Q (filed 2020-05-08) ↗ |
| Q4 2018 | Dec 31, 2018 | 43 | -63.6% | Form 10-K (filed 2020-02-21) ↗ |
| Q3 2018 | Sep 30, 2018 | 23 | -87.3% | Form 10-Q (filed 2019-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | 41 | – | Form 10-Q (filed 2019-08-05) ↗ |
| Q1 2018 | Mar 31, 2018 | 68 | – | Form 10-Q (filed 2019-05-03) ↗ |
| Q4 2017 | Dec 31, 2017 | 118 | – | Form 10-K (filed 2020-02-21) ↗ |
| Q3 2017 | Sep 30, 2017 | 181 | – | Form 10-Q (filed 2018-11-07) ↗ |
Cite this data
StockData. (2026). AbbVie Viekira (ombitasvir/paritaprevir/ritonavir) [legacy through FY20Q1] — International net revenues ($M) ($M), quarterly Q3 2017–Q1 2020 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/viekira_intl
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.